ProBio

Antibody-drug conjugate
#Antibody drug conjugate (ADC) #Collaboration #ProBio #Therapeutic Antibodies

ProBio and AbTis partner on next-generation antibody-drug conjugate

CRDMO ProBio and South Korean biotechnology company AbTis have agreed an exclusive global licensing agreement for the development of antibody-drug conjugates (ADCs).  AbTis will receive exclusive global rights to develop and commercialise a discovery-stage therapeutic antibody asset generated through ProBio’s biologics discovery and development capabilities against an… Read More

#Business & Investment #News

#Drug development #Drug discovery #Interview #ProBio #Sitting Down With #Vodcast

New vodcast: Sitting Down With… Derek Chen, ProBio

The latest episode of the DDW Sitting Down With vodcast is sponsored by ProBio, and our guest is Derek Chen, who Multimedia Editor Megan Thomas interviewed on how AI is transforming antibody drug discovery, from identifying and prioritising candidates to early developability assessment, experimental validation and the integration of discovery,… Read More

#News

#Drug development #Drug discovery #Interview #ProBio #Sitting Down With #Vodcast

Vodcast: Sitting Down With… Derek Chen, ProBio

The latest episode of the DDW Sitting Down With vodcast is sponsored by ProBio, and our guest is Derek Chen, who Multimedia Editor Megan Thomas interviewed on how AI is transforming antibody drug discovery, from identifying and prioritising candidates to early developability assessment, experimental validation and the integration of discovery,… Read More

#Videos